News

It's been a rough year for Sarepta Therapeutics (NASDAQ: SRPT), a small-cap biotech that develops medicines for rare diseases. The company's shares are down by 88% year to date due to safety issues

Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on treatments for obesity and metabolic diseases, released results for its second quarter on July 23, 2025. The

AT&T (NYSE: T) released its latest set of quarterly results Wednesday morning. While these weren't strong enough to bring the bulls charging into the stock, they were nevertheless pleasing for

AT&T (NYSE:T), a U.S. telecommunications and connectivity provider, released its Q2 2025 earnings on July 23, 2025. The company posted adjusted earnings per share of $0.54, just above the average

Boston Scientific (NYSE:BSX), a leader in medical devices for cardiovascular and surgical markets, reported its second-quarter 2025 results on July 23, 2025. The company posted revenue and earnings

First Horizon (NYSE:FHN), a regional banking group focused on retail and commercial lending in the Southeast, released its second quarter 2025 earnings on July 16, 2025. The most important news was

AT&T (NYSE:T), a major U.S. telecommunications company known for wireless and fiber broadband services, released its second-quarter 2025 results on July 23, 2025. The company reported revenue of

There are no guarantees on Wall Street, especially when it comes to dividends. The board of directors of each company decides on the dividend in private. But income investors can glean some

What makes a good dividend stock? The answer depends a bit on who's looking, of course. But there are some general themes that can be drawn out by looking at Johnson & Johnson (NYSE: JNJ) and

Nvidia (NASDAQ: NVDA) shares declined 2.5% to close at $167.03 on July 22 as investors engaged in profit-taking following the stock's post-earnings rally. Approximately 183 million shares of the

First Financial (NASDAQ:THFF), a regional bank serving the Midwest and Southeast, delivered fiscal 2025 second-quarter results on Tuesday, July 22, that topped analysts' consensus expectations

Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged

A stock market that keeps reaching all-time highs hardly seems like anything for investors to complain about. But if you're trying to build a growing stream of passive income, extended bull markets

The trade war between the U.S. and China recently took an unexpected turn, and the biggest beneficiaries look to be Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). Both stocks popped

It's been an awful, horrible, lousy year so far for UnitedHealth Group (NYSE: UNH). If I opened a thesaurus, I could easily find plenty of other apt descriptions for the healthcare giant's

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, long-term investors should have a balanced approach to potentially

AT&T (NYSE: T) stock moved higher in Monday's trading. The telecommunications company's share price gained 1.6% in the daily session amid a 0.1% gain for the S&P 500 index and a 0.3% gain for the

In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other semiconductor companies. To learn more, check out the short video,

Three years ago, Summit Therapeutics (NASDAQ: SMMT) was a little-known small-cap biotech that few investors with an average tolerance for risk would have bothered to pay attention to at the time

Pharmaceutical giants Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) have lagged the market over the past year, although Pfizer's poor performance dates back much further. Though these companies

There is a lot you can do with $1,000. But if you want to get a step closer to sustainable wealth, consider putting that money to work in the stock market. The burgeoning generative artificial